Stocks Comparison
Fortrea vs Veracyte: revenue, profit, margins and growth compared
Fortrea brought in $2.7B of revenue in fiscal 2025, Veracyte $517.1M in fiscal 2025. Revenue changed by +1.0% at Fortrea and +16.0% at Veracyte on the year before, so Veracyte grew faster. Fortrea kept -36.2% of its revenue as net profit, Veracyte 12.8%. Free cash flow was $88.3M at Fortrea and $126.6M at Veracyte.
Side by side, latest fiscal year
| FTRE | VCYT | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $2.7B | $517.1M |
| Revenue growth | +1.0% | +16.0% |
| Net income | -$986.2M | $66.4M |
| Net margin | -36.2% | 12.8% |
| Free cash flow | $88.3M | $126.6M |
| Free cash flow margin | 3.2% | 24.5% |
| Earnings per share (diluted) | -$10.81 | $0.82 |
| Cash | $174.6M | $362.6M |
| Debt | $1.1B | n/a |
| Price to earnings | n/a | 55.4 |
| Market value | $1.9B | $3.7B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #91 of 523 · Health care | #190 of 523 · Health care |
Over the years
Questions about Fortrea and Veracyte
Which is bigger by revenue, Fortrea or Veracyte?
Fortrea is bigger by revenue: $2.7B in fiscal 2025, against $517.1M for Veracyte in fiscal 2025.
Which keeps more of its revenue as profit, Fortrea or Veracyte?
Fortrea had a net margin of -36.2% in fiscal 2025; Veracyte had 12.8% in fiscal 2025.
Which grew revenue faster, Fortrea or Veracyte?
In their latest fiscal years revenue changed by +1.0% at Fortrea and +16.0% at Veracyte.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.